The Effect of Antithrombin III on the Activity of the Coagulation Factors VII, IX and X

B Østerud; M Miller-Andersson; U Abildgaard; H Prydz

doi:10.1055/s-0038-1647922

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 1976; 35(02): 295-304
DOI: 10.1055/s-0038-1647922

Original Article

Schattauer GmbH

The Effect of Antithrombin III on the Activity of the Coagulation Factors VII, IX and X

Autor*innen

B Østerud

¹Institute of Medical Biology, University of Tromsø, Norway, Research Department, AB Kabi, Stockholm, Sweden and Department of Medicine A, Aker Hospital, Oslo, Norway
M Miller-Andersson

¹Institute of Medical Biology, University of Tromsø, Norway, Research Department, AB Kabi, Stockholm, Sweden and Department of Medicine A, Aker Hospital, Oslo, Norway
U Abildgaard

¹Institute of Medical Biology, University of Tromsø, Norway, Research Department, AB Kabi, Stockholm, Sweden and Department of Medicine A, Aker Hospital, Oslo, Norway
H Prydz

¹Institute of Medical Biology, University of Tromsø, Norway, Research Department, AB Kabi, Stockholm, Sweden and Department of Medicine A, Aker Hospital, Oslo, Norway

Abstract

Summary

Antithrombin III, purified to homogeneity according to Polyacrylamide gel disc electrophoresis and immunoelectrophoresis, inhibited the activity of purified factor IXa and Xa, whereas factor VII was not inhibited either in the active or in the native form.

Antithrombin III is the single most important inhibitor of factor Xa in plasma. Factor Xa does not, however, reduce the activity of antithrombin III against thrombin.

Volltext

Referenzen

References
1 Abildgaard U. 1967; a Purification of two progressive antithrombins of human plasma. Scandinavian Journal of Clinical and Laboratory Investigation 19: 190.
2 Abildgaard U. 1967; b Inhibition of thrombin-fibrinogen reaction by antithrombin III, studied by N-terminal analysis. Scandinavian Journal of Clinical and Laboratory Investigation 20: 207.
3 Abildgaard U. 1969; Inhibition of thrombin-fibrinogen reaction by α₂-macroglobulin, studied by N-terminal analysis. Thrombosis et Diathesis Haemorrhagica 21: 173.
4 Biggs R, Denson K. W. E, Akman N, Borret R, Had den M. 1970; Antithrombin III, antifactor Xa and heparin. British Journal of Haematology 19: 283.
5 Damus P. S, Hicks M, Rosenberg R. D. 1973; Anticoagulant action of heparin. Nature 246: 355.
6 Davis B. J. 1964; Disc electrophoresis LI. Method and application to human serum protein. Annals of the New York Academy of Sciences 121: 404.
7 Egeberg O. 1965; a Inherited antithrombin deficiency causing thrombophilia. Thrombosis et Diathesis Haemorrhagica 13: 516.
8 Egeberg O. 1965; b Thrombophilia caused by inheritable deficiency of blood antithrombin. Scandinavian Journal of Clinical and Laboratory Investigation 17: 92.
9 Fagerhol M. K, Abildgaard U. 1970; Immunological studies on human antithrombin III. Scandinavian Journal of Haematology 7: 10.
10 Gladhaug Å, Prydz H. 1970; Purification of the coagulation factors VII and X from human serum. Some properties of factor VII. Biochimica et Biophysica Acta 215: 105.
11 Gladhaug Berre Å, Østerud B, Christensen T. B, Holm T, Prydz H. 1973; Some characteristics of the coagulation factor Xa purified from human serum. Biochemical Journal 135: 791.
12 Godal H. C, Rygh M, Laake K. 1974; Progressive inactivation of purified factor VII heparin and antithrombin III. Thrombosis Research 5: 773.
13 Highsmith R. F, Rosenberg R. D. 1974; The inhibition of human plasmili by human antithrom-bin-heparin cofactor. Journal of Biological Chemistry 249: 4335.
14 Hjort P. F, Rapaport S. I, Owren P. A. 1955; A simple specific one-stage prothrombin assay using Russell’s viper venom in cephalin suspension. Journal of Laboratory and Clinical Medicine 46: 89.
15 Hjort P. F. 1957; Intermediate reactions in the coagulation of blood with tissue thromboplastin. Scandinavian Journal of Clinical and Laboratory Investigations 9 suppl. 27.
16 Hvatum M, Prydz H. 1966; Studies on tissue thromboplastin I. Solubilization with deoxycholate. Biochimica et Biophysica Acta 130: 92.
17 Hvatum M, Prydz H. 1969; Studies on tissue thromboplastin. Its splitting into two separable parts. Thrombosis et Diathesis Haemorrhagica 21: 217.
18 Laemmli U. K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage. Nature 227: 680.
19 Lanchantin G. F, Plesset M. L, Friedmann I. A, Hart D. W. 1966; Dissociation of esterolytic and clotting activities of thrombin by trypsin-binding macroglobulin. Proceedings of the Society for Experimental Biology and Medicine, (N. Y.) 121: 444.
20 Lowry O. H, Rosebrough N. J, Farr A. L, Randall R. J. 1951; Protein measurement with the folin phenol reagent. Journal of Biological Chemistry 193: 265.
21 Mancini G, Carbonara A. O, Heremans J. F. 1965; Immunochemical quantitation of antigens by single radial immunodiffusion. International Journal of Immunochemistry 2: 235.
22 Osamo N. O. 1971; Evidence that antithrombin and the inhibitor of activated Stuart-Prower factor are separate entities. Blut 23: 280.
23 Prydz H. 1964; Studies on proconvertin IV. The adsorption to barium sulphate. Scandinavian Journal of Clinical and Laboratory Investigations 16: 409.
24 Reisfeld R. A, Lewis U. J, Williams D. E. 1962; Disc electrophoresis of basic proteins and peptides on polyacrylamide gels. Nature 195: 281.
25 Rinderknecht H, Geokas M. G. 1972; Role for α₂-macroglobulin in haemostatic balance. Nature 239: 116.
26 Rinderknecht H, Geokas M. G. 1973; On the physiological role of α₂-microglobulin. Biochimica et Biophysica Acta 295: 233.
27 Rosenberg R, Damus P. S. 1973; The purification and mechanism of action of human antithrombin-heparin cofactor. Journal of Biological Chemistry 248: 6490.
28 Scheidegger J. J. 1955; Une microméthode de l’immuno-électrophorese. International Archives of Allergy 7: 103.
29 Seegers W. H, Marciniak E. 1962; Inhibition of autoprothrombin C activity with plasma. Nature 193: 1188.
30 Skotland T, Holm T, Østerud B, Flengsrud R, Prydz H. 1974; The localization of a vitamin K-induced modification in an N-terminal fragment of human prothrombin. Biochemical Journal 143: 29.
31 Steinbuch M, Blatrix C, Josso F. 1967; α-Macroglobulin as progressive antithrombin. Nature 216: 500.
32 Vesterberg O, Svensson H. 1966; Isoelectric fractionation, analysis and characterization of ampholytes in natural pH gradients. IV. Acta Chemica Scandinavica 20: 820.
33 Yin E. T, Wessler S, Stoll P. J. 1971; a Rabbit plasma inhibitor of the activated species of blood coagulation factor. Journal of Biological Chemistry 246: 3694.
34 Yin E. T, Wessler S, Stoll P. J. 1971; b Biological properties of the naturally occurring plasma inhibitor to activated factor X. Journal of Biological Chemistry 246: 3703.
35 Yin E. T, Wessler S, Stoll P. J. 1971; c Identity of plasma-activated f actor X inhibitor with antithrombin III and heparin cofactor. Journal of Biological Chemistry, 246: 3712.
36 Østerud B, Berre Å, Otnæss A.-B, Bjørklid E, Prydz H. 1972; Activation of the coagulation factor VII by tissue thromboplastin and calcium. Biochemistry 11: 2853.
37 Østerud B, Flengsrud R. 1975; Purification and some characteristics of the coagulation factor IX from human plasma. Biochemical Journal 145: 469.
38 Østerud B, Laake K, Prydz H. 1975; The activation of human factor IX. Thrombosis et Diathesis Haemorrhagica 34: 167.